Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FRHsEBBpBIu59jOIhXQhFk4TO8fI.uncropped.jpg&w=3840&q=75)
Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page
- ChecktodayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 34 locations, and the website has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of 'Follicular Lymphoma Lymphosarcoma' has been updated to 'Lymphosarcoma Follicular Lymphoma' in the web page, reflecting a revision from v2.9.3 to v2.9.5.SummaryDifference0.3%
- Check31 days agoChange DetectedThe value on the webpage has changed from 'Lymphosarcoma Follicular Lymphoma Revision: v2.9.1' to 'Follicular Lymphoma Lymphosarcoma Revision: v2.9.3'. This change represents an update in the revision version from v2.9.1 to v2.9.3 for the mentioned conditions.SummaryDifference0.3%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus related topics: Lymphoma Genetic and Rare Diseases Information Center resources: Lymphosarcoma Follicular Lymphoma Drug Information available for: Idelalisib Loncastuximab tesirine FDA Drug and Device Resources'. This change represents an update in the information related to the study, including additional resources and drug information.SummaryDifference35%
Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.